RecruitingPhase 3NCT05879926Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Sponsor: NRG OncologyCamden, NJ · Cherry Hill, NJ · Elizabeth, NJ · +1223 more sites
RecruitingPhase 3NCT05812807Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus PembrolizumabSponsor: Alliance for Clinical Trials in OncologyCamden, NJ · Cherry Hill, NJ · Elizabeth, NJ · +825 more sites
RecruitingPhase 2NCT05559164Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 TargetedSponsor: Rutgers, The State University of New JerseyElizabeth, NJ · Hamilton, NJ · Jersey City, NJ · +7 more sites
RecruitingPhase 4NCT07158164DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-AdjustmentSponsor: Rutgers, The State University of New JerseyBelleville, NJ · Elizabeth, NJ · Hamilton, NJ · +9 more sites